ReviewFrontiers in surgery2015
Retroperitoneal liposarcoma: current insights in diagnosis and treatment.
Review in Frontiers in surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
76 citing papers in PubMed, 143 citations in OpenAlex.
- Monte Carlo-based characterization of proton minibeam radiation therapy across clinically relevant beam parameters.Physics and imaging in radiation oncology · 2026Article
- Giant Retroperitoneal Liposarcoma Without Organ Invasion: A Rare Case Report.The American journal of case reports · 2026Article
- Retroperitoneal myxoid liposarcoma in a 3.5-year-old Afghan child: a case report and review of the literature.Oxford medical case reports · 2026Article
- Article
- Dedifferentiated Liposarcoma of the Epididymis: A Rare Case Report and AnalysisCurrent medical imaging · 2026Article
- Component-based CT radiomics for preoperative differentiation of well-differentiated and dedifferentiated retroperitoneal liposarcoma.Frontiers in oncology · 2026Article
- Extracellular Vesicle- MDM2 -DNA as a Potential Liquid Biopsy Biomarker for Disease Identification in Retroperitoneal Liposarcoma.Annals of surgery · 2025Article
- Perinephric myxoid pseudotumor of fat - histopathological and molecular characterization of 3 cases after renal transplantation.Diagnostic pathology · 2025Article
- Review
- Case Report: an extremely rare case of giant dedifferentiated retroperitoneal liposarcoma.Frontiers in oncology · 2025Article
- Pseudo-beer belly disguised and presenting as inguinal hernia swelling: a case of massive retroperitoneal liposarcoma.Frontiers in medicine · 2025Article
- Retroperitoneal dedifferentiated liposarcoma with colon infiltration: a case report and literature review.Frontiers in oncology · 2025Article
- Recurrent dedifferentiated liposarcoma with histological grade progression: a case report.Ecancermedicalscience · 2025Article
- Efficacy of surgery in the management of multiple recurrences of retroperitoneal dedifferentiated liposarcoma.World journal of surgical oncology · 2024Article
- A rare well-differentiated renal retroperitoneal liposarcoma: a case report.Annals of medicine and surgery (2012) · 2024Article
- Giant retroperitoneal liposarcoma with multiple organ involvement: a case report and literature review.BMC nephrology · 2024Review
- An overview on liposarcoma subtypes: Genetic alterations and recent advances in therapeutic strategies.Journal of molecular histology · 2024Review
- Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio.Annals of surgical oncology · 2024Article
- Retroperitoneal Liposarcoma: Rational Extent of Surgery Tailored to Grade of Malignancy.Indian journal of surgical oncology · 2024Article
- Prediction of Recurrence-Free and Overall Survival in Retroperitoneal Well-Differentiated and Dedifferentiated Liposarcoma After Surgery.Indian journal of surgical oncology · 2024Article
16 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retroperitoneal liposarcoma (RLS) is a rare, biologically heterogeneous tumor that present considerable challenges due to its size and deep location. As a consequence, the majority of patients with high-grade RLS will develop locally recurrent disease following surgery, and this constitutes the cause of death in most patients. Here, we review current insights and controversies regarding histology, molecular biology, extent of surgery, (neo)adjuvant treatment, and systemic treatment including novel targeted agents in RLS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.